• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症中的胆固醇代谢:机制与治疗机遇。

Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities.

机构信息

State Key Laboratory of Molecular Biology, Shanghai Science Research Center, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, China.

Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan, China.

出版信息

Nat Metab. 2020 Feb;2(2):132-141. doi: 10.1038/s42255-020-0174-0. Epub 2020 Feb 10.

DOI:10.1038/s42255-020-0174-0
PMID:32694690
Abstract

Cholesterol metabolism produces essential membrane components as well as metabolites with a variety of biological functions. In the tumour microenvironment, cell-intrinsic and cell-extrinsic cues reprogram cholesterol metabolism and consequently promote tumourigenesis. Cholesterol-derived metabolites play complex roles in supporting cancer progression and suppressing immune responses. Preclinical and clinical studies have shown that manipulating cholesterol metabolism inhibits tumour growth, reshapes the immunological landscape and reinvigorates anti-tumour immunity. Here, we review cholesterol metabolism in cancer cells, its role in cancer progression and the mechanisms through which cholesterol metabolites affect immune cells in the tumour microenvironment. We also discuss therapeutic strategies aimed at interfering with cholesterol metabolism, and how the combination of such approaches with existing anti-cancer therapies can have synergistic effects, thus offering new therapeutic opportunities.

摘要

胆固醇代谢产生必需的膜成分以及具有多种生物学功能的代谢物。在肿瘤微环境中,细胞内和细胞外的信号重新编程胆固醇代谢,从而促进肿瘤发生。胆固醇衍生的代谢物在支持癌症进展和抑制免疫反应方面发挥着复杂的作用。临床前和临床研究表明,操纵胆固醇代谢可以抑制肿瘤生长、重塑免疫景观并重新激活抗肿瘤免疫。在这里,我们综述了癌细胞中的胆固醇代谢、它在癌症进展中的作用以及胆固醇代谢物影响肿瘤微环境中免疫细胞的机制。我们还讨论了旨在干扰胆固醇代谢的治疗策略,以及这些方法与现有的抗癌疗法相结合如何产生协同效应,从而为新的治疗机会提供了可能。

相似文献

1
Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities.癌症中的胆固醇代谢:机制与治疗机遇。
Nat Metab. 2020 Feb;2(2):132-141. doi: 10.1038/s42255-020-0174-0. Epub 2020 Feb 10.
2
Metabolic reprogramming of the tumour microenvironment.肿瘤微环境的代谢重编程。
FEBS J. 2015 Oct;282(20):3892-8. doi: 10.1111/febs.13402. Epub 2015 Aug 25.
3
Cholesterol metabolism: New functions and therapeutic approaches in cancer.胆固醇代谢:癌症的新功能和治疗方法。
Biochim Biophys Acta Rev Cancer. 2020 Aug;1874(1):188394. doi: 10.1016/j.bbcan.2020.188394. Epub 2020 Jul 19.
4
Membrane Cholesterol Efflux Drives Tumor-Associated Macrophage Reprogramming and Tumor Progression.膜胆固醇外排驱动肿瘤相关巨噬细胞重编程和肿瘤进展。
Cell Metab. 2019 Jun 4;29(6):1376-1389.e4. doi: 10.1016/j.cmet.2019.02.016. Epub 2019 Mar 28.
5
Immunometabolic Checkpoints of Treg Dynamics: Adaptation to Microenvironmental Opportunities and Challenges.调节性 T 细胞动力学的免疫代谢检查点:适应微环境的机遇与挑战。
Front Immunol. 2019 Aug 27;10:1889. doi: 10.3389/fimmu.2019.01889. eCollection 2019.
6
Cholesterol metabolism: At the cross road between cancer cells and immune environment.胆固醇代谢:癌细胞与免疫微环境的十字路口。
Int J Biochem Cell Biol. 2020 Dec;129:105876. doi: 10.1016/j.biocel.2020.105876. Epub 2020 Nov 6.
7
Multifunctional Nanomaterials Mediate Cholesterol Depletion for Cancer Treatment.多功能纳米材料介导胆固醇耗竭用于癌症治疗。
Angew Chem Int Ed Engl. 2024 Nov 11;63(46):e202412844. doi: 10.1002/anie.202412844. Epub 2024 Oct 4.
8
Targeting T cell metabolism in the tumor microenvironment: an anti-cancer therapeutic strategy.靶向肿瘤微环境中的 T 细胞代谢:一种抗癌治疗策略。
J Exp Clin Cancer Res. 2019 Sep 13;38(1):403. doi: 10.1186/s13046-019-1409-3.
9
Targeting cholesterol metabolism in Cancer: From molecular mechanisms to therapeutic implications.靶向癌症中的胆固醇代谢:从分子机制到治疗意义。
Biochem Pharmacol. 2023 Dec;218:115907. doi: 10.1016/j.bcp.2023.115907. Epub 2023 Nov 4.
10
The role of cholesterol metabolism in lung cancer.胆固醇代谢在肺癌中的作用。
Oncol Res. 2024 Sep 18;32(10):1613-1621. doi: 10.32604/or.2024.047933. eCollection 2024.

引用本文的文献

1
Exploratory evaluation of immunotherapy response and medication use in endometrial and cervical carcinoma.子宫内膜癌和宫颈癌免疫治疗反应及药物使用的探索性评估
Gynecol Oncol Rep. 2025 Jun 21;60:101782. doi: 10.1016/j.gore.2025.101782. eCollection 2025 Aug.
2
Dual molecularly imprinted nanocomposite with transferrin mediated glioma targeting and cholesterol exhaustion for synergistic cuproptosis/immune checkpoint blockade/immunogenic cell death.具有转铁蛋白介导的胶质瘤靶向和胆固醇耗竭功能的双分子印迹纳米复合材料,用于协同铜死亡/免疫检查点阻断/免疫原性细胞死亡。
Mater Today Bio. 2025 Aug 16;34:102209. doi: 10.1016/j.mtbio.2025.102209. eCollection 2025 Oct.
3

本文引用的文献

1
Mevalonate Pathway Provides Ubiquinone to Maintain Pyrimidine Synthesis and Survival in p53-Deficient Cancer Cells Exposed to Metabolic Stress.甲羟戊酸途径为 p53 缺陷型肿瘤细胞在代谢应激下维持嘧啶合成和生存提供泛醌。
Cancer Res. 2020 Jan 15;80(2):189-203. doi: 10.1158/0008-5472.CAN-19-0650. Epub 2019 Nov 19.
2
Potentiation of Kras peptide cancer vaccine by avasimibe, a cholesterol modulator.胆固醇调节剂阿伐麦布增强 Kras 肽癌症疫苗。
EBioMedicine. 2019 Nov;49:72-81. doi: 10.1016/j.ebiom.2019.10.044. Epub 2019 Oct 31.
3
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis.
NeuroD1 drives a KAT2A-FDFT1 signaling axis to promote cholesterol biosynthesis and hepatocellular carcinoma progression via histone H3K27 acetylation.
NeuroD1驱动KAT2A-FDFT1信号轴,通过组蛋白H3K27乙酰化促进胆固醇生物合成和肝细胞癌进展。
Oncogene. 2025 Sep 1. doi: 10.1038/s41388-025-03534-6.
4
Bladder Cancer: Role of Circular RNAs in Oncogenesis, Tumor Suppression, and Therapeutic Target Identification.膀胱癌:环状RNA在肿瘤发生、肿瘤抑制及治疗靶点识别中的作用
Cancer Genomics Proteomics. 2025 Sep-Oct;22(5):654-682. doi: 10.21873/cgp.20528.
5
Targeting STARD4/EGFR axis inhibits growth and overcomes lenvatinib resistance in hepatocellular carcinoma.靶向STARD4/EGFR轴可抑制肝癌生长并克服乐伐替尼耐药性。
Genes Dis. 2025 Feb 15;12(6):101556. doi: 10.1016/j.gendis.2025.101556. eCollection 2025 Nov.
6
BMI1 regulates human erythroid self-renewal through both gene repression and gene activation.BMI1通过基因抑制和基因激活来调节人类红细胞的自我更新。
Nat Commun. 2025 Aug 15;16(1):7619. doi: 10.1038/s41467-025-62993-3.
7
Dysregulated Cholesterol Metabolism and Its Impact on the Tumour Immune Response in Colorectal Cancer.胆固醇代谢失调及其对结直肠癌肿瘤免疫反应的影响
J Cell Mol Med. 2025 Aug;29(15):e70789. doi: 10.1111/jcmm.70789.
8
Angulin-1/LSR inhibition transiently disrupts the blood-tumor barrier to enhance doxil permeability and impair malignant glioma progression.血管四联蛋白-1/白细胞特异性受体酪氨酸激酶抑制可短暂破坏血脑肿瘤屏障,增强阿霉素的通透性,并抑制恶性胶质瘤进展。
bioRxiv. 2025 Aug 2:2025.07.31.667901. doi: 10.1101/2025.07.31.667901.
9
Explore the potential mechanism of Huachansu injection against osteosarcoma via metabolomics, network pharmacology and bioinformatics.通过代谢组学、网络药理学和生物信息学探索华蟾素注射液抗骨肉瘤的潜在机制。
Chin Med. 2025 Aug 5;20(1):120. doi: 10.1186/s13020-025-01179-x.
10
Comprehensive analysis of cholesterol metabolism-related genes in prostate cancer: integrated analysis of single-cell and bulk RNA sequencing.前列腺癌中胆固醇代谢相关基因的综合分析:单细胞和批量RNA测序的整合分析
Discov Oncol. 2025 Jul 30;16(1):1442. doi: 10.1007/s12672-025-03294-5.
辅酶 Q 氧化还原酶 FSP1 与 GPX4 平行作用以抑制铁死亡。
Nature. 2019 Nov;575(7784):688-692. doi: 10.1038/s41586-019-1705-2. Epub 2019 Oct 21.
4
FSP1 is a glutathione-independent ferroptosis suppressor.FSP1 是一种谷胱甘肽不依赖的铁死亡抑制因子。
Nature. 2019 Nov;575(7784):693-698. doi: 10.1038/s41586-019-1707-0. Epub 2019 Oct 21.
5
RORγ is a targetable master regulator of cholesterol biosynthesis in a cancer subtype.RORγ 是一种癌症亚型中胆固醇生物合成的可靶向主调控因子。
Nat Commun. 2019 Oct 11;10(1):4621. doi: 10.1038/s41467-019-12529-3.
6
Targeting the Metabolic Response to Statin-Mediated Oxidative Stress Produces a Synergistic Antitumor Response.靶向他汀类药物介导的氧化应激的代谢反应可产生协同的抗肿瘤反应。
Cancer Res. 2020 Jan 15;80(2):175-188. doi: 10.1158/0008-5472.CAN-19-0644. Epub 2019 Sep 27.
7
The Cytokine TNF Promotes Transcription Factor SREBP Activity and Binding to Inflammatory Genes to Activate Macrophages and Limit Tissue Repair.细胞因子 TNF 促进转录因子 SREBP 的活性和与炎症基因的结合,从而激活巨噬细胞并限制组织修复。
Immunity. 2019 Aug 20;51(2):241-257.e9. doi: 10.1016/j.immuni.2019.06.005. Epub 2019 Jul 11.
8
Increased Cholesterol Biosynthesis Is a Key Characteristic of Breast Cancer Stem Cells Influencing Patient Outcome.胆固醇生物合成增加是影响患者预后的乳腺癌干细胞的一个关键特征。
Cell Rep. 2019 Jun 25;27(13):3927-3938.e6. doi: 10.1016/j.celrep.2019.05.104.
9
Targeting the transcription factor receptor LXR to treat clear cell renal cell carcinoma: agonist or inverse agonist?靶向转录因子受体 LXR 治疗透明细胞肾细胞癌:激动剂还是反向激动剂?
Cell Death Dis. 2019 May 28;10(6):416. doi: 10.1038/s41419-019-1654-6.
10
Cholesterol Induces CD8 T Cell Exhaustion in the Tumor Microenvironment.胆固醇在肿瘤微环境中诱导 CD8 T 细胞耗竭。
Cell Metab. 2019 Jul 2;30(1):143-156.e5. doi: 10.1016/j.cmet.2019.04.002. Epub 2019 Apr 25.